{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:34:16Z","timestamp":1787567656675,"version":"build-2736575974"},"reference-count":136,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Nicolaus Copernicus University"},{"id":[{"id":"https:\/\/ror.org\/0102mm775","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Melanoma, a skin cancer with the highest mortality rate, poses a significant medical challenge. Despite the revolution in the treatment of this cancer brought about by the development of immunotherapy and targeted therapies using BRAF\/MEK inhibitors, the complex mutation profile and the development of drug resistance compel researchers to seek new solutions. Cyclin-dependent kinases (CDKs), a group of enzymes regulating fundamental processes in every eukaryotic cell, are generating significant interest in the context of potential targeted therapies for melanoma. The best-studied CDKs, responsible for controlling specific phases of the cell-cycle, have been extensively described in the literature, and their inhibition is increasingly used as a treatment for various cancers. However, in addition to the classic cell-cycle CDKs, CDKs regulating transcription can also be distinguished. Other family members responsible for tissue-specific processes are commonly referred to as atypical or untypical CDKs. These include CDK5, which plays a critical role in the nervous system. In recent years, a growing body of research has focused on the role of transcriptional and atypical CDKs in the progression of cancers, including melanoma. However, their precise function remains unclear. This paper will provide an overview of the role of CDKs, other than cell cycle CDKs, in melanoma development and provide a comprehensive understanding of their potential use in future targeted therapies. The advantages and disadvantages of inhibiting these kinases in melanoma therapy will be discussed, as well as the synergies with various molecular pathways analyzed to date.<\/jats:p>","DOI":"10.3390\/cancers18172726","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:20:02Z","timestamp":1787563202000},"page":"2726","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Transcriptional and Atypical Cyclin-Dependent Protein Kinases in Melanoma"],"prefix":"10.3390","volume":"18","author":[{"given":"Jonatan","family":"Kaszubski","sequence":"first","affiliation":[{"name":"Vascular Biology Student Research Club, Department of Histology and Embryology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-092 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5445-8821","authenticated-orcid":false,"given":"Maciej","family":"Gagat","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-092 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8568-1770","authenticated-orcid":false,"given":"Agata","family":"Wawrzyniak","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Institute of Medical Sciences, College of Medical Sciences of the University of Rzesz\u00f3w, 35-310 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6919-0004","authenticated-orcid":false,"given":"Agnieszka","family":"\u017bury\u0144","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-092 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12935-024-03220-9","article-title":"Melanoma Biology and Treatment: A Review of Novel Regulated Cell Death-Based Approaches","volume":"24","author":"Hsieh","year":"2024","journal-title":"Cancer Cell Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"107955","DOI":"10.1016\/j.phrs.2025.107955","article-title":"Advances in Cutaneous Melanoma Therapy: The Emerging Role of CDK4\/6 Inhibitors","volume":"221","author":"Kim","year":"2025","journal-title":"Pharmacol. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/CMR.0b013e328351fa4d","article-title":"A Brief History of Melanoma: From Mummies to Mutations","volume":"22","author":"Rebecca","year":"2012","journal-title":"Melanoma Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"112531","DOI":"10.1016\/j.ejmech.2020.112531","article-title":"Getting under the Skin: The Role of CDK4\/6 in Melanomas","volume":"204","author":"Guo","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41392-024-02080-z","article-title":"Cyclin-Dependent Protein Kinases and Cell Cycle Regulation in Biology and Disease","volume":"10","author":"Pellarin","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00432-022-04135-6","article-title":"Cyclins and Cyclin-Dependent Kinases: From Biology to Tumorigenesis and Therapeutic Opportunities","volume":"149","author":"Zabihi","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"180112","DOI":"10.1098\/rsob.180112","article-title":"Structural Insights into the Functional Diversity of the CDK\u2013Cyclin Family","volume":"8","author":"Wood","year":"2018","journal-title":"Open Biol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"\u0141ukasik, P., Za\u0142uski, M., and Gutowska, I. (2021). Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development\u2013Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062935"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Wang, Z. (2021). Regulation of Cell Cycle Progression by Growth Factor-Induced Cell Signaling. Cells, 10.","DOI":"10.3390\/cells10123327"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.semcancer.2022.12.006","article-title":"CDK Inhibitors from Past to Present: A New Wave of Cancer Therapy","volume":"88","author":"Mughal","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1126\/science.adw0053","article-title":"Structural Basis of T-Loop\u2013Independent Recognition and Activation of CDKs by the CDK-Activating Kinase","volume":"390","author":"Cushing","year":"2025","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1038\/s41388-022-02347-1","article-title":"Transcription Associated Cyclin-Dependent Kinases as Therapeutic Targets for Prostate Cancer","volume":"41","author":"Constantin","year":"2022","journal-title":"Oncogene"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Liang, S., Hu, L., Wu, Z., Chen, Z., Liu, S., Xu, X., and Qian, A. (2020). CDK12: A Potent Target and Biomarker for Human Cancer Therapy. Cells, 9.","DOI":"10.3390\/cells9061483"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molmed.2024.09.004","article-title":"Emerging Roles of Cyclin-Dependent Kinase 7 in Health and Diseases","volume":"31","author":"Belew","year":"2025","journal-title":"Trends Mol. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.celrep.2017.07.021","article-title":"Human TFIIH Kinase CDK7 Regulates Transcription-Associated Chromatin Modifications","volume":"20","author":"Ebmeier","year":"2017","journal-title":"Cell Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1128\/MCB.00637-09","article-title":"TFIIH-Associated Cdk7 Kinase Functions in Phosphorylation of C-Terminal Domain Ser7 Residues, Promoter-Proximal Pausing, and Termination by RNA Polymerase II","volume":"29","author":"Larochelle","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/21541264.2019.1597479","article-title":"Transcriptional CDKs in the Spotlight","volume":"10","author":"Espinosa","year":"2019","journal-title":"Transcription"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e29736","DOI":"10.7554\/eLife.29736","article-title":"CDK9-Dependent RNA Polymerase II Pausing Controls Transcription Initiation","volume":"6","author":"Gressel","year":"2017","journal-title":"eLife"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.molcel.2025.03.021","article-title":"Tripartite Phosphorylation of SPT5 by CDK9 Times Pause Release and Tunes Elongation Rate of RNA Polymerase II","volume":"85","author":"Sun","year":"2025","journal-title":"Mol. Cell"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Alrouji, M., Alshammari, M.S., Anwar, S., Venkatesan, K., and Shamsi, A. (2025). Mechanistic Roles of Transcriptional Cyclin-Dependent Kinases in Oncogenesis: Implications for Cancer Therapy. Cancers, 17.","DOI":"10.3390\/cancers17091554"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"103714","DOI":"10.1016\/j.dnarep.2024.103714","article-title":"Mediator Complex in Transcription Regulation and DNA Repair: Relevance for Human Diseases","volume":"141","author":"Maalouf","year":"2024","journal-title":"DNA Repair"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/21541264.2018.1556915","article-title":"Regulatory Functions of the Mediator Kinases CDK8 and CDK19","volume":"10","author":"Fant","year":"2018","journal-title":"Transcription"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"113043","DOI":"10.1016\/j.ejmech.2020.113043","article-title":"Angel or Devil?\u2014CDK8 as the New Drug Target","volume":"213","author":"Wu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"20955","DOI":"10.1074\/jbc.M113.486746","article-title":"Mediator Complex Recruits Epigenetic Regulators via Its Two Cyclin-Dependent Kinase Subunits to Repress Transcription of Immune Response Genes","volume":"288","author":"Tsutsui","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1101\/gad.1767009","article-title":"The Human CDK8 Subcomplex Is a Molecular Switch That Controls Mediator Coactivator Function","volume":"23","author":"Knuesel","year":"2009","journal-title":"Genes. Dev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nsmb.1752","article-title":"CDK8 Is a Positive Regulator of Transcriptional Elongation within the Serum Response Network","volume":"17","author":"Donner","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nature09380","article-title":"Mediator and Cohesin Connect Gene Expression and Chromatin Architecture","volume":"467","author":"Kagey","year":"2010","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nature14904","article-title":"Mediator Kinase Inhibition Further Activates Super-Enhancer-Associated Genes in AML","volume":"526","author":"Pelish","year":"2015","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2013.04.048","article-title":"HIF1A Employs CDK8-Mediator to Stimulate RNAPII Elongation in Response to Hypoxia","volume":"153","author":"Galbraith","year":"2013","journal-title":"Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s44318-023-00024-x","article-title":"The Mediator Kinase Module Enhances Polymerase Activity to Regulate Transcriptional Memory after Heat Stress in Arabidopsis","volume":"43","author":"Crawford","year":"2024","journal-title":"EMBO J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.molcel.2019.07.034","article-title":"Transcriptional Responses to IFN-\u03b3 Require Mediator Kinase-Dependent Pause Release and Mechanistically Distinct CDK8 and CDK19 Functions","volume":"76","author":"Steinparzer","year":"2019","journal-title":"Mol. Cell"},{"key":"ref_32","first-page":"e54261","article-title":"CDK8 and CDK19 Act Redundantly to Control the CFTR Pathway in the Intestinal Epithelium","volume":"24","author":"Prieto","year":"2022","journal-title":"EMBO Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nchembio.1952","article-title":"A Selective Chemical Probe for Exploring the Role of CDK8 and CDK19 in Human Disease","volume":"11","author":"Dale","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1021\/acs.jmedchem.5b01685","article-title":"Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19","volume":"59","author":"Mallinger","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.1093\/nar\/gkaa514","article-title":"CDK12 Globally Stimulates RNA Polymerase II Transcription Elongation and Carboxyl-Terminal Domain Phosphorylation","volume":"48","author":"Tellier","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.celrep.2015.12.025","article-title":"Structural and Functional Analysis of the Cdk13\/Cyclin K Complex","volume":"14","author":"Greifenberg","year":"2016","journal-title":"Cell Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-018-0758-y","article-title":"Cdk12 Regulates DNA Repair Genes by Suppressing Intronic Polyadenylation","volume":"564","author":"Dubbury","year":"2018","journal-title":"Nature"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/s41467-018-04258-w","article-title":"Cyclin K Regulates Prereplicative Complex Assembly to Promote Mammalian Cell Proliferation","volume":"9","author":"Lei","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"8623","DOI":"10.1074\/jbc.M210057200","article-title":"CDK11 Complexes Promote Pre-mRNA Splicing","volume":"278","author":"Hu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Ahmed, R.L., Shaughnessy, D.P., Knutson, T.P., Vogel, R.I., Ahmed, K., Kren, B.T., and Trembley, J.H. (2019). CDK11 Loss Induces Cell Cycle Dysfunction and Death of BRAF and NRAS Melanoma Cells. Pharmaceuticals, 12.","DOI":"10.3390\/ph12020050"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41586-022-05204-z","article-title":"CDK11 Regulates Pre-mRNA Splicing by Phosphorylation of SF3B1","volume":"609","author":"Kluge","year":"2022","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.jid.2017.09.056","article-title":"High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma","volume":"138","author":"Eliades","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12943-019-1070-7","article-title":"Transcriptional Inhibition by CDK7\/9 Inhibitor SNS-032 Abrogates Oncogene Addiction and Reduces Liver Metastasis in Uveal Melanoma","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e51683","DOI":"10.15252\/embr.202051683","article-title":"CDK7 and MITF Repress a Transcription Program Involved in Survival and Drug Tolerance in Melanoma","volume":"22","author":"Berico","year":"2021","journal-title":"EMBO Rep."},{"key":"ref_45","first-page":"1429","article-title":"Epigenetic Inhibitors Eliminate Senescent Melanoma BRAFV600E Cells That Survive Long-Term BRAF Inhibition","volume":"56","author":"Rowdo","year":"2020","journal-title":"Int. J. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41419-020-02971-3","article-title":"CDK9 Activity Is Critical for Maintaining MDM4 Overexpression in Tumor Cells","volume":"11","author":"Verlande","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.jid.2020.12.035","article-title":"The Molecular Context of Vulnerability for CDK9 Suppression in Triple Wild-Type Melanoma","volume":"141","author":"Guhan","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.jid.2020.12.038","article-title":"A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma","volume":"141","author":"Emran","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/CMR.0000000000000853","article-title":"LS-007 Inhibits Melanoma Growth via Inducing Apoptosis and Cell Cycle Arrest and Regulating Macrophage Polarization","volume":"32","author":"Yin","year":"2022","journal-title":"Melanoma Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41388-024-02947-z","article-title":"Unique Vulnerability of RAC1-Mutant Melanoma to Combined Inhibition of CDK9 and Immune Checkpoints","volume":"43","author":"Cannon","year":"2024","journal-title":"Oncogene"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41420-023-01754-x","article-title":"The CDK12 Inhibitor SR-4835 Functions as a Molecular Glue That Promotes Cyclin K Degradation in Melanoma","volume":"9","author":"Houles","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"116495","DOI":"10.1016\/j.celrep.2025.116495","article-title":"CDK12 Inhibition Reveals Melanoma Dependence on the RUNX1\/CBF\u03b2 Complex for Genomic Stability","volume":"44","author":"Boucher","year":"2025","journal-title":"Cell Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"190287","DOI":"10.1098\/rsob.190287","article-title":"A Kinase of Many Talents: Non-Neuronal Functions of CDK5 in Development and Disease","volume":"10","author":"Sharma","year":"2020","journal-title":"Open Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12943-024-02043-6","article-title":"Insights into the Structural and Functional Activities of Forgotten Kinases: PCTAIREs CDKs","volume":"23","author":"Karimbayli","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"114929","DOI":"10.1016\/j.biopha.2023.114929","article-title":"The Roles, Molecular Interactions, and Therapeutic Value of CDK16 in Human Cancers","volume":"164","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2174\/1389450124666230719102112","article-title":"The Role of CDK20 Protein in Carcinogenesis","volume":"24","author":"Chivukula","year":"2023","journal-title":"Curr. Drug Targets"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s41586-024-07888-x","article-title":"CDK5\u2013Cyclin B1 Regulates Mitotic Fidelity","volume":"633","author":"Zheng","year":"2024","journal-title":"Nature"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12929-021-00774-y","article-title":"Three Decades of Cdk5","volume":"28","author":"Pao","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Do, P.A., and Lee, C.H. (2020). The Role of CDK5 in Tumours and Tumour Microenvironments. Cancers, 13.","DOI":"10.3390\/cancers13010101"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"17373","DOI":"10.18632\/oncotarget.14538","article-title":"Biological Functions of CDK5 and Potential CDK5 Targeted Clinical Treatments","volume":"8","author":"Shupp","year":"2017","journal-title":"Oncotarget"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11626-019-00343-6","article-title":"Cyclin-Dependent Kinase 5 Regulates Proliferation, Migration, Tyrosinase Activity, and Melanin Production in B16-F10 Melanoma Cells via the Essential Regulator p-CREB","volume":"55","author":"Li","year":"2019","journal-title":"In Vitro Cell. Dev. Biol.-Anim."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.apsb.2019.07.004","article-title":"Cdk5 Knocking out Mediated by CRISPR-Cas9 Genome Editing for PD-L1 Attenuation and Enhanced Antitumor Immunity","volume":"10","author":"Deng","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"8001","DOI":"10.1073\/pnas.1912617117","article-title":"Targeting the Cyclin-Dependent Kinase 5 in Metastatic Melanoma","volume":"117","author":"Sharma","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1038\/mtna.2016.40","article-title":"Lipid Nanoparticle-Mediated siRNA Transfer Against PCTAIRE1\/PCTK1\/Cdk16 Inhibits In Vivo Cancer Growth","volume":"5","author":"Yanagi","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_65","first-page":"1246","article-title":"LncRNA HCG18 Facilitates Melanoma Progression by Modulating miR-324-5p\/CDK16 Axis","volume":"14","author":"Zhang","year":"2022","journal-title":"Am. J. Transl. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1080\/15384047.2019.1640032","article-title":"Current State of Melanoma Diagnosis and Treatment","volume":"20","author":"Davis","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Caraviello, C., Nazzaro, G., Tavoletti, G., Boggio, F., Denaro, N., Murgia, G., Passoni, E., Mancin, V.B., and Marzano, A.V. (2025). Melanoma Skin Cancer: A Comprehensive Review of Current Knowledge. Cancers, 17.","DOI":"10.3390\/cancers17172920"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Motwani, J., and Eccles, M.R. (2021). Genetic and Genomic Pathways of Melanoma Development, Invasion and Metastasis. Genes, 12.","DOI":"10.3390\/genes12101543"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.gendis.2022.04.004","article-title":"Melanoma: Molecular Genetics, Metastasis, Targeted Therapies, Immunotherapies, and Therapeutic Resistance","volume":"9","author":"Wagstaff","year":"2022","journal-title":"Genes Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct Sets of Genetic Alterations in Melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1016\/j.jid.2017.07.832","article-title":"Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma","volume":"137","author":"Thomas","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.cmr.0000232300.22032.86","article-title":"NRAS and BRAF Mutations in Melanoma Tumours in Relation to Clinical Characteristics: A Study Based on Mutation Screening by Pyrosequencing","volume":"16","author":"Omholt","year":"2006","journal-title":"Melanoma Res."},{"key":"ref_73","first-page":"5761","article-title":"Absence of BRAF and NRAS Mutations in Uveal Melanoma","volume":"63","author":"Cruz","year":"2003","journal-title":"Cancer Res."},{"key":"ref_74","unstructured":"(2015). The Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell, 161, 1681\u20131696."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/pcmr.12459","article-title":"The Genomic Landscape of Cutaneous Melanoma","volume":"29","author":"Zhang","year":"2016","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The Genetic Evolution of Melanoma from Precursor Lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/CMR.0000000000000777","article-title":"Targeting Cyclin-Dependent Kinase 4\/6 as a Therapeutic Approach for Mucosal Melanoma","volume":"31","author":"Shi","year":"2021","journal-title":"Melanoma Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus Ipilimumab in Advanced Melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_79","first-page":"472","article-title":"Melanoma Staging: Evidence-Based Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1406037","article-title":"Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma","volume":"371","author":"Long","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF Gene in Human Cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent Somatic Mutations of GNAQ in Uveal Melanoma and Blue Naevi","volume":"457","author":"Bezrookove","year":"2009","journal-title":"Nature"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Garutti, M., Targato, G., Buriolla, S., Palmero, L., Minisini, A.M., and Puglisi, F. (2021). CDK4\/6 Inhibitors in Melanoma: A Comprehensive Review. Cells, 10.","DOI":"10.3390\/cells10061334"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Hung, C., Nguyen, T.T.T., Poulikakos, P.I., and Polsky, D. (2025). Recent Developments in Targeting the Cell Cycle in Melanoma. Cancers, 17.","DOI":"10.3390\/cancers17081291"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMoa1607303","article-title":"Palbociclib and Letrozole in Advanced Breast Cancer","volume":"375","author":"Finn","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_87","first-page":"876","article-title":"Differential Expression of Gl Cyclins and Cyclin-Dependent Kinase Inhibitors in Normal and Transformed Melanocytes","volume":"39","author":"Mouriaux","year":"1998","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_88","first-page":"7114","article-title":"Lower Cyclin H and Cyclin-Dependent Kinase-Activating Kinase Activity in Cell Cycle Arrest Induced by Lack of Adhesion to Substratum","volume":"60","author":"Solorzano","year":"2000","journal-title":"Cancer Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/ijc.21478","article-title":"Signalling Responses Linked to Betulinic Acid-Induced Apoptosis Are Antagonized by MEK Inhibitor U0126 in Adherent or 3D Spheroid Melanoma Irrespective of P53 Status","volume":"118","author":"Rieber","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1038\/s41388-018-0661-x","article-title":"Lineage-Specific Control of TFIIH by MITF Determines Transcriptional Homeostasis and DNA Repair","volume":"38","author":"Seoane","year":"2019","journal-title":"Oncogene"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"100060","DOI":"10.1016\/j.apjo.2024.100060","article-title":"Uveal Melanoma: Current Evidence on Prognosis, Treatment and Potential Developments","volume":"13","author":"Gelmi","year":"2024","journal-title":"Asia-Pac. J. Ophthalmol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/nature09590","article-title":"The Histone Variant macroH2A Suppresses Melanoma Progression through Regulation of CDK8","volume":"468","author":"Kapoor","year":"2010","journal-title":"Nature"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jgg.2011.09.002","article-title":"Dysregulation of CDK8 and Cyclin C in Tumorigenesis","volume":"38","author":"Xu","year":"2011","journal-title":"J. Genet. Genom."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1128\/JVI.07006-11","article-title":"Retroviral Cyclin Enhances Cyclin-Dependent Kinase-8 Activity","volume":"86","author":"Rovnak","year":"2012","journal-title":"J. Virol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"118287","DOI":"10.1016\/j.bmc.2025.118287","article-title":"A Comprehensive Description of Cyclin-Dependent Kinase 8 (CDK8) Inhibitors as Anticancer Agents","volume":"128","author":"Liu","year":"2025","journal-title":"Bioorganic Med. Chem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.3892\/mmr.2014.2482","article-title":"MacroH2A Suppresses the Proliferation of the B16 Melanoma Cell Line","volume":"10","author":"Lei","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.celrep.2013.07.012","article-title":"CDK8-Mediated STAT1-S727 Phosphorylation Restrains NK Cell Cytotoxicity and Tumor Surveillance","volume":"4","author":"Putz","year":"2013","journal-title":"Cell Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1158\/2326-6066.CIR-17-0183","article-title":"NK Cell\u2013Specific CDK8 Deletion Enhances Antitumor Responses","volume":"6","author":"Gotthardt","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1158\/1535-7163.MCT-19-0789","article-title":"Selective and Potent CDK8\/19 Inhibitors Enhance NK Cell Activity and Promote Tumor Surveillance","volume":"19","author":"Hofmann","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Roninson, I.B., Gy\u0151rffy, B., Mack, Z.T., Shtil, A.A., Shtutman, M.S., Chen, M., and Broude, E.V. (2019). Identifying Cancers Impacted by CDK8\/19. Cells, 8.","DOI":"10.3390\/cells8080821"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Lucci, V., De Marino, E., Tagliaferri, D., Amente, S., Pollice, A., Calabr\u00f2, V., Vivo, M., Falco, G., and Angrisano, T. (2022). Identification of Cdk8 and Cdkn2d as New Prame-Target Genes in 2C-like Embryonic Stem Cells. Genes, 13.","DOI":"10.3390\/genes13101745"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e14418","DOI":"10.1111\/cbdd.14418","article-title":"Multifaceted Approach toward Mapping out the Anticancer Properties of Small Molecules via in Vitro Evaluation on Melanoma and Nonmelanoma Skin Cancer Cells, and in Silico Target Fishing","volume":"103","author":"Boateng","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4161\/cc.10.6.15079","article-title":"Expression Analysis and Molecular Targeting of Cyclin-Dependent Kinases in Advanced Melanoma: Functional Analysis and Molecular Targeting of Cyclin-Dependent Kinase Family Members in Advanced Melanoma","volume":"10","author":"Abdullah","year":"2011","journal-title":"Cell Cycle"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/1878-0261.12148","article-title":"Molecular Profiling and Combinatorial Activity of CCT068127: A Potent CDK2 and CDK9 Inhibitor","volume":"12","author":"Whittaker","year":"2018","journal-title":"Mol. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ejmech.2018.09.025","article-title":"Discovery of 4-(((4-(5-Chloro-2-(((1s,4s)-4-((2-Methoxyethyl)Amino)Cyclohexyl)Amino)Pyridin-4-Yl)Thiazol-2-Yl)Amino)Methyl)Tetrahydro-2H-Pyran-4-Carbonitrile (JSH-150) as a Novel Highly Selective and Potent CDK9 Kinase Inhibitor","volume":"158","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_106","first-page":"e59910","article-title":"A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers","volume":"151","author":"Modur","year":"2019","journal-title":"J. Vis. Exp."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11912-015-0485-6","article-title":"Molecular Targeted Therapy Approaches for BRAF Wild-Type Melanoma","volume":"18","author":"Johnpulle","year":"2016","journal-title":"Curr. Oncol. Rep."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/ncb2309","article-title":"E2F Transcription Factor-1 Regulates Oxidative Metabolism","volume":"13","author":"Blanchet","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e202500305","DOI":"10.1002\/cmdc.202500305","article-title":"Cyclin-Dependent Kinase 11: Cellular Functions and Potential Therapeutic Applications","volume":"20","author":"Shrestha","year":"2025","journal-title":"ChemMedChem"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1042\/BJ20040848","article-title":"Regulation of Stability of Cyclin-Dependent Kinase CDK11p110 and a Caspase-Processed Form, CDK11p46, by Hsp90","volume":"384","author":"Mikolajczyk","year":"2004","journal-title":"Biochem. J."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.bbrc.2005.07.026","article-title":"The Cyclin-Dependent Kinase 11 Interacts with NOT2","volume":"334","author":"Shi","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1042\/BJ20050195","article-title":"Death-Signal-Induced Relocalization of Cyclin-Dependent Kinase 11 to Mitochondria","volume":"392","author":"Feng","year":"2005","journal-title":"Biochem. J."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"101173","DOI":"10.1016\/j.jpha.2024.101173","article-title":"New Insights into the Dule Roles CDK12 in Human Cancers: Mechanisms and Interventions for Cancer Therapy","volume":"15","author":"Dai","year":"2025","journal-title":"J. Pharm. Anal."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.1038\/s41467-022-34179-8","article-title":"CDK12 Is Hyperactivated and a Synthetic-Lethal Target in BRAF-Mutated Melanoma","volume":"13","author":"Houles","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4049\/jimmunol.2100963","article-title":"Identification of RPL15 60S Ribosomal Protein as a Novel Topotecan Target Protein That Correlates with DAMP Secretion and Antitumor Immune Activation","volume":"209","author":"Yamada","year":"2022","journal-title":"J. Immunol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/mc.70040","article-title":"Inhibiting Cyclin-Dependent Kinase 13-Mediated Nuclear Ubiquitous Casein Kinase and Cyclin-Dependent Kinase Substrate 1 Phosphorylation Facilitates Oxidative Stress-Induced Apoptosis in Melanoma","volume":"64","author":"Pan","year":"2025","journal-title":"Mol. Carcinog."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1042\/BCJ20220075","article-title":"NUCKS1 Is a Highly Modified, Chromatin-Associated Protein Involved in a Diverse Set of Biological and Pathophysiological Processes","volume":"479","author":"Grundt","year":"2022","journal-title":"Biochem. J."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"eabn7625","DOI":"10.1126\/science.abn7625","article-title":"Oncogenic CDK13 Mutations Impede Nuclear RNA Surveillance","volume":"380","author":"Insco","year":"2023","journal-title":"Science"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/01635589709514610","article-title":"Tyrosine and Phenylalanine Restriction Induces G0\/G1 Cell Cycle Arrest in Murine Melanoma In Vitro and In Vivo","volume":"29","author":"Fu","year":"1997","journal-title":"Nutr. Cancer"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e815","DOI":"10.1038\/cddis.2013.353","article-title":"EGFR\/MEK\/ERK\/CDK5-Dependent Integrin-Independent FAK Phosphorylated on Serine 732 Contributes to Microtubule Depolymerization and Mitosis in Tumor Cells","volume":"4","author":"Rea","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7603\/s40681-014-0022-1","article-title":"Retinoic Acid and Cancer Treatment","volume":"4","author":"Chen","year":"2014","journal-title":"BioMedicine"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.tranon.2015.06.002","article-title":"Cyclin-Dependent Kinase 5 (CDK5) Controls Melanoma Cell Motility, Invasiveness, and Metastatic Spread\u2014Identification of a Promising Novel Therapeutic Target","volume":"8","author":"Bisht","year":"2015","journal-title":"Transl. Oncol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.18632\/oncotarget.6842","article-title":"Inhibition of Endothelial Cdk5 Reduces Tumor Growth by Promoting Non-Productive Angiogenesis","volume":"7","author":"Merk","year":"2016","journal-title":"Oncotarget"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.trecan.2016.09.001","article-title":"The Emerging Role of Cdk5 in Cancer","volume":"2","author":"Pozo","year":"2016","journal-title":"Trends Cancer"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"13783","DOI":"10.1038\/s41598-017-12567-1","article-title":"Functional Role of Cyclin-Dependent Kinase 5 in the Regulation of Melanogenesis and Epidermal Structure","volume":"7","author":"Dong","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.ajpath.2018.06.017","article-title":"The HU177 Collagen Epitope Controls Melanoma Cell Migration and Experimental Metastasis by a CDK5\/YAP-Dependent Mechanism","volume":"188","author":"Caron","year":"2018","journal-title":"Am. J. Pathol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.aae0477","article-title":"Cdk5 Disruption Attenuates Tumor PD-L1 Expression and Promotes Antitumor Immunity","volume":"353","author":"Dorand","year":"2016","journal-title":"Science"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molcel.2019.09.030","article-title":"Mechanisms Controlling PD-L1 Expression in Cancer","volume":"76","author":"Cha","year":"2019","journal-title":"Mol. Cell"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"107847","DOI":"10.1016\/j.bioorg.2024.107847","article-title":"Heterocycle-Functional Steroidal Derivatives: Design, Synthesis, Bioevaluation and SARs of Steroidal Pyrazolo[1,5-a]Pyrimidines as Potential ALK Inhibitors","volume":"153","author":"Liu","year":"2024","journal-title":"Bioorganic Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00403-025-03961-1","article-title":"Clinical Implications and Molecular Mechanism of Long Noncoding RNA LINC00518 and Protein-Coding Genes in Skin Cutaneous Melanoma by Genome-wide Investigation","volume":"317","author":"Wang","year":"2025","journal-title":"Arch. Dermatol. Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"108390","DOI":"10.1016\/j.compbiolchem.2025.108390","article-title":"Phytoflavonoids as Alternative Therapeutic Effect for Melanoma: Integrative Network Pharmacology, Molecular Dynamics and Drug-Likeness Profiling for Lead Discovery","volume":"117","author":"Prajapati","year":"2025","journal-title":"Comput. Biol. Chem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/1878-0261.12152","article-title":"Dabrafenib Inhibits the Growth of BRAF-WT Cancers through CDK16 and NEK9 Inhibition","volume":"12","author":"Phadke","year":"2018","journal-title":"Mol. Oncol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jdermsci.2017.02.281","article-title":"PCTAIRE1\/CDK16\/PCTK1 Is Overexpressed in Cutaneous Squamous Cell Carcinoma and Regulates P27 Stability and Cell Cycle","volume":"86","author":"Yanagi","year":"2017","journal-title":"J. Dermatol. Sci."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"141141","DOI":"10.1016\/j.bbapap.2026.141141","article-title":"Computational Phosphoproteomic Insights into Predominant BRAF Phosphosites and Associated Regulatory Networks in Cancer","volume":"1874","author":"Dcunha","year":"2026","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1038\/s41467-023-40061-y","article-title":"Dose Escalation and Expansion Cohorts in Patients with Advanced Breast Cancer in a Phase I Study of the CDK7-Inhibitor Samuraciclib","volume":"14","author":"Coombes","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e47925e9","DOI":"10.1097\/01.HS9.0000971400.47925.e9","article-title":"P1126: PHASE 1B\/2A STUDY OF AZD4573 (CDK9I) AND ACALABRUTINIB IN PATIENTS (PTS) WITH RELAPSED\/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R\/R DLBCL)","volume":"7","author":"Strati","year":"2023","journal-title":"Hemasphere"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/17\/2726\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:31:30Z","timestamp":1787563890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/17\/2726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":136,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cancers18172726"],"URL":"https:\/\/doi.org\/10.3390\/cancers18172726","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]}}}